Funding for this research was provided by:
Innovative Medicines Initiative
Received: 29 December 2021
Accepted: 26 March 2022
First Online: 7 May 2022
: DN, WM and EM are employees of Hoffmann La Roche. GFE is co-founder of Phenris GmbH. The authors declare no other conflict of interests.
: This paper reflects only the authors´ view. Innovative Medicines Initiative 2 Joint Undertaking is not responsible for any use that may be made of the information it contains.